Equity Profile

MDT

Medtronic plc

Health CareHealth Care Equipment$107.0B

Jun3Wed

Pre-Earnings Brief

UpcomingQ4-2026Pre-Market9:00 AM EDT

Company Snapshot

Medtronic plc (MDT) is a leading global healthcare technology company that develops and manufactures medical devices and therapies. With a market cap of $107 billion, it plays a crucial role in improving patient outcomes across various medical conditions, particularly in areas like cardiovascular and diabetes care.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

$1.55

Revenue

Revenue growth reflects the company's ability to sell its products and services effectively, which is critical for sustaining operations.

$9.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

MDT Q4-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+1.42%

Avg Stock Reaction

-2.31%

Last Quarter Recap

In Q3-2026, Medtronic reported an EPS of $1.36, slightly beating estimates. However, the stock fell 3.10% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Focus on expanding product lines in cardiovascular and diabetes care.
Commitment to improving operational efficiencies.
Plans to enhance digital health solutions.

Expectations

Wall Street Expectations

Analysts expect Medtronic to report solid earnings, with an EPS of $1.55 and revenue of $9.6 billion. The market is closely watching for any signs of growth in key segments.

Bull Case

If Medtronic exceeds EPS expectations and shows strong revenue growth, it could signal robust demand for its products, potentially boosting investor confidence.

Bear Case

Conversely, if the company misses estimates or provides weak guidance, it could raise concerns about its market position and future growth prospects.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.55

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$9.6B

Revenue growth reflects the company's ability to sell its products and services effectively, which is critical for sustaining operations.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $1.55?

A beat on EPS could indicate strong operational performance and boost investor sentiment.

What guidance will management provide regarding revenue growth?

Guidance on revenue growth will be critical in assessing the company's outlook and potential for future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Medtronic to exceed EPS expectations due to strong demand in its diabetes segment, which has been growing faster than anticipated.

Supporting Evidence

Recent product launches in diabetes care have received positive feedback from healthcare providers.

Options market is pricing a 5.32% move, suggesting expectations are higher than historical averages.

The company's commitment to operational efficiencies may lead to better margins than analysts expect.

Key Risk

If revenue growth significantly outpaces expectations, it could challenge the current consensus view.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Medtronic can maintain its growth trajectory amidst competitive pressures and economic challenges.

Bull Confirmed If

An EPS of $1.60 or higher would confirm the bull case, indicating stronger than expected profitability.

Bear Confirmed If

An EPS below $1.52 would confirm the bear case, raising concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±5.32%

Historical Avg

±3.6%

Pricing rich

The options market is pricing in a significant move around the earnings report, suggesting that investors are anticipating volatility.

Options are pricing ±5.3% while MDT has averaged ±3.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

25.1%

Calls (1.1M)P/C Ratio: 0.55Puts (351K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Medtronic beats expectations, history suggests the stock could rise by around 4.69%, confirming strong demand for its products.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

If the company misses estimates, history suggests a potential decline of around 3.14%, reflecting investor disappointment.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$15,001.00–$50,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on the performance of new diabetes care products.
2Management's commentary on operational efficiencies and cost management.
3Insights into market trends affecting cardiovascular devices.
4Guidance on revenue expectations for the upcoming fiscal year.
5Details on competitive pressures in the healthcare equipment sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jun1

SAICBMO

Science Applications International Corporation

PreviewView

Jun1

CRDOAMC

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

$1.55

Revenue

Revenue growth reflects the company's ability to sell its products and services effectively, which is critical for sustaining operations.

$9.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

MDT Q4-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+1.42%

Avg Stock Reaction

-2.31%

Last Quarter Recap

In Q3-2026, Medtronic reported an EPS of $1.36, slightly beating estimates. However, the stock fell 3.10% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Focus on expanding product lines in cardiovascular and diabetes care.
Commitment to improving operational efficiencies.
Plans to enhance digital health solutions.

Expectations

Wall Street Expectations

Analysts expect Medtronic to report solid earnings, with an EPS of $1.55 and revenue of $9.6 billion. The market is closely watching for any signs of growth in key segments.

Bull Case

If Medtronic exceeds EPS expectations and shows strong revenue growth, it could signal robust demand for its products, potentially boosting investor confidence.

Bear Case

Conversely, if the company misses estimates or provides weak guidance, it could raise concerns about its market position and future growth prospects.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.55

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$9.6B

Revenue growth reflects the company's ability to sell its products and services effectively, which is critical for sustaining operations.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $1.55?

A beat on EPS could indicate strong operational performance and boost investor sentiment.

What guidance will management provide regarding revenue growth?

Guidance on revenue growth will be critical in assessing the company's outlook and potential for future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Medtronic to exceed EPS expectations due to strong demand in its diabetes segment, which has been growing faster than anticipated.

Supporting Evidence

Recent product launches in diabetes care have received positive feedback from healthcare providers.

Options market is pricing a 5.32% move, suggesting expectations are higher than historical averages.

The company's commitment to operational efficiencies may lead to better margins than analysts expect.

Key Risk

If revenue growth significantly outpaces expectations, it could challenge the current consensus view.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Medtronic can maintain its growth trajectory amidst competitive pressures and economic challenges.

Bull Confirmed If

An EPS of $1.60 or higher would confirm the bull case, indicating stronger than expected profitability.

Bear Confirmed If

An EPS below $1.52 would confirm the bear case, raising concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±5.32%

Historical Avg

±3.6%

Pricing rich

The options market is pricing in a significant move around the earnings report, suggesting that investors are anticipating volatility.

Options are pricing ±5.3% while MDT has averaged ±3.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

25.1%

Calls (1.1M)P/C Ratio: 0.55Puts (351K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Medtronic beats expectations, history suggests the stock could rise by around 4.69%, confirming strong demand for its products.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

If the company misses estimates, history suggests a potential decline of around 3.14%, reflecting investor disappointment.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$15,001.00–$50,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on the performance of new diabetes care products.
2Management's commentary on operational efficiencies and cost management.
3Insights into market trends affecting cardiovascular devices.
4Guidance on revenue expectations for the upcoming fiscal year.
5Details on competitive pressures in the healthcare equipment sector.